Rice Hall James & Associates’s Enovis ENOV Stock Holding History
Bought
Maintained
Sold
Other funds holding ENOV
DCP
CB
CCMLC
EC
Rice Hall James & Associates's ENOV Position: Q2 2022 in Review
Rice Hall James & Associates sold out of Enovis (ENOV) in Q2 2022, closing a stake of 4,416 shares — an estimated $302K sold.
Rice Hall James & Associates first reported a position in ENOV in Q3 2020 and held it in 7 quarters. The position peaked at $350K in Q4 2021. 245 funds tracked by Wall St. Rank hold ENOV as of Q2 2022.
- Rice Hall James & Associates reported no remaining Enovis position as of Q2 2022 after selling out during the quarter.
- Rice Hall James & Associates sold 4,416 Enovis shares in Q2 2022, an estimated $302K.
- Rice Hall James & Associates first reported a position in Enovis in Q3 2020 and held it in 7 quarters.
- Rice Hall James & Associates's Enovis position peaked at $350K in Q4 2021.
- 245 funds tracked by Wall St. Rank held Enovis as of Q2 2022.
Based on Rice Hall James & Associates's 13F filing for Q2 2022, filed 8 Aug 2022.